We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

NFE2L2 rs6706649: Understanding Your Genetic Variant

rs6706649
Trait
Moderate evidenceGene: NFE2L2

The rs6706649 variant is a single nucleotide polymorphism (SNP) located in the promoter region of the NFE2L2 gene. This gene encodes the NRF2 protein, a master regulator that helps the body manage oxidative stress and inflammation.

What each genotype means

C/CLower attention

Common NFE2L2 promoter profile

This genotype represents the most common configuration for this promoter region variant. Research into this specific SNP is ongoing, and while it is located in a region that influences NRF2 expression, there is currently no definitive clinical consensus on how this specific genotype impacts overall antioxidant response or health outcomes.

This is the most frequent genotype observed in most global populations.

C/TLower attention

Heterozygous NFE2L2 promoter variant

Carrying one copy of the T allele means your genetic profile for this promoter region differs from the most common form. Some research has explored associations between the T allele and specific biochemical markers, such as thyroglobulin levels, but these findings are not diagnostic and do not indicate a specific health condition.

This genotype is found in a minority of individuals, with the T allele occurring at a global minor allele frequency of approximately 7.8%.

T/TLower attention

Variant NFE2L2 promoter profile

This genotype represents the homozygous state for the less common T allele. While this SNP is situated in the promoter region of the NFE2L2 gene, which regulates antioxidant pathways, current scientific evidence does not establish this genotype as a cause of any specific disease or clinical phenotype.

This is the least common genotype, occurring in a small fraction of the population consistent with the minor allele frequency of the T allele.

What is rs6706649 and Where is it Located?

The variant rs6706649 is a specific change in the DNA sequence located on chromosome 2. It sits within the promoter region of the NFE2L2 gene. A promoter is a critical regulatory segment of DNA that acts like a switch, determining how much of a specific protein is produced by the cell. Because this SNP is located in a regulatory area rather than the protein-coding sequence itself, it is hypothesized to influence the expression levels of the NRF2 protein. Researchers study such variants to understand how subtle differences in our genetic code might lead to variations in how our cells respond to environmental stressors. While the physical location is well-mapped in the human genome, the functional impact of this specific change remains a subject of ongoing scientific investigation.

The Role of the NFE2L2 Gene

The NFE2L2 gene provides instructions for making a protein called NRF2. This protein is a transcription factor, meaning it binds to specific sequences of DNA to turn other genes on or off. NRF2 is widely recognized as the master regulator of the cellular antioxidant response. When cells experience oxidative stress—often caused by injury, inflammation, or environmental toxins—NRF2 moves into the cell nucleus. Once there, it binds to antioxidant response elements (ARE) in the promoters of various cytoprotective genes. This process triggers the production of enzymes that neutralize harmful free radicals and protect the cell from damage. By maintaining redox homeostasis, NRF2 is essential for cell survival and the body's ability to recover from various forms of cellular insult.

Research Associations and Evidence Strength

Research into rs6706649 has explored its potential role in various health conditions, though the evidence remains moderate or limited. Some studies have investigated whether this variant influences the body's response to oxidative stress or its association with complex conditions like Parkinson's disease or diabetic complications. For instance, some researchers have examined whether this SNP correlates with differences in enzyme levels, such as glyoxalase-1, in patients with specific metabolic conditions. However, results across different studies have often been inconsistent or non-significant. It is important to note that many of these associations are statistical in nature and do not imply a direct cause-and-effect relationship. Because the evidence is not definitive, this variant is not currently used as a clinical diagnostic tool, and its broader impact on human health is still being evaluated by the scientific community.

What You Can Do With This Information

Understanding your genetic variants can be an interesting way to learn about your biological makeup, but it is important to maintain a balanced perspective. Because the association between rs6706649 and specific health outcomes is not fully established, this information should not be used to make medical decisions or to predict your personal health risks. Genetic variants are only one piece of a much larger puzzle that includes your environment, lifestyle, and other genetic factors. If you have questions about your health, your risk for specific conditions, or how to support your body's antioxidant defenses, the best approach is to consult with a qualified healthcare professional. They can provide personalized guidance based on your full medical history rather than a single genetic marker. Always prioritize evidence-based medical advice over individual SNP reports.

How common is this variant?

The frequency of the rs6706649 variant is variable across different ancestral groups, with a global minor allele frequency reported around 0.078 in some databases.

Frequently asked questions

Is rs6706649 a dangerous mutation?

No, rs6706649 is a common genetic variant, not a disease-causing mutation. It is a normal variation in the human genome that may influence gene expression levels but is not inherently harmful.

Can I use this SNP to predict my risk of disease?

No. Current research does not support using this SNP to predict individual disease risk. The associations found in studies are statistical and do not provide a clear clinical picture for any one person.

Does this variant affect how I should take medication?

There is no evidence that this variant requires changes to medication dosing. If you have concerns about your medications, please discuss them with your doctor or pharmacist.

Where can I find more information about NFE2L2?

You can find reliable information about the NFE2L2 gene and its function on resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.

Sources & further reading

Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs6706649?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in NFE2L2